Michael P. Lilly, MD is a Professor in the Department of Surgery, Division of Vascular Surgery at the University of Maryland School of Medicine. He serves as the Chief of the Department of Surgery at the University of Maryland Medical Center Midtown Campus (formerly Maryland General Hospital) and he is the Director of the Maryland Vascular Center at the Midtown Campus. Dr. Lilly received a B.A. (Mathematics) at the College of the Holy Cross in 1973 and an M.A. (Mathematics) at Columbia University in 1974. He received his MD at Georgetown University in 1978. After internship and residency in Surgery at Brown University, including a 2 year fellowship in surgical research, he trained in vascular surgery at Northwestern University as the Conrad Jobst Fellow. He joined the faculty at the University of Maryland in 1989, and he was the director of Non-invasive Vascular Diagnostic Lab for the next ten years. He was Chief of Vascular Surgery at the Baltimore VA Medical Center from 1999 to 2004, after which he the leadership position in Surgery at Maryland General Hospital. He has served on the editorial boards of the Journal of Surgical Research and the Journal of Vascular Surgery.
Dr. Lilly is a nationally recognized expert in the Non-invasive (ultrasound) diagnosis of vascular diseases. He has done research on the clinical applications of non-invasive diagnostic methods and has been engaged in national efforts to enhance the quality and accuracy of vascular ultrasound. He serves on the Boards of Directors of both the Intersocietal Accreditation Commission for Vascular Testing and the American Registry for Diagnostic Medical Sonography, the largest international accreditation and certification organizations for vascular ultrasound. He has written over 50 peer-reviewed published scientific articles and authored 12 book chapters. He has been the Principal Investigator or co-investigator on 17 sponsored research contracts at the School of Medicine dealing with peripheral artery disease, wound healing, and the treatment of aortic aneurysms.
Dr. Lilly is the Director of the Maryland Vascular Center at Midtown Campus and his clinical interests focus on peripheral artery disease and the management of hemodialysis access. Dr. Lilly was a leader in the Centers for Medicare and Medicaid Services Fistula First Breakthrough Initiative and served as the National Surgical Clinical Consultant to the Program for 5 years. He is a recognized national expert in dialysis access planning, construction and maintenance and was the leader to the surgical education programs of the Fistula First Program.
Costanza, M.J., Queral, L.A., Lilly, M.P., Flinn, W.R. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus Type B femoropopliteal arterial occlusive lesions. J Vasc Surg 39:343-50, 2004.
Busuttil, S.J., Schilling, R., Lilly, M.P., Neschis, D.G., Flinn, W.R. Recurrence of femoral pseudoaneurysm after ultrasound-guided thrombin injection. J Vasc Ultrasound 30:159-61, 2006.
Willis, M., Neschis, D.G., Menaker, J., Lilly, M.P., Scalea, T.M. Stent grafting for a distal thoracic aortic injury. Vasc Endovasc Surg 45:187-190, 2011.
Chan, K.E., Pflederer, T.A., Steele, D.J.R., Lilly, M.P., Alp Ikizler, T., Maddux, F.W., Hakin, R.M. Access survival amongst hemodialysis patients referred for preventative angiography and percutaneous transluminal angioplasty. Clinical Journal of the American Society of Nephrology 6:2669-80, 2011.
Lilly, M.P., Lynch, J.R., Wish, J., Huff, E.D., Chen, S-C, Armistead, N.C., McClellen, W.M. Prevalence of arteriovenous fistulae in incident hemodialysis patients: correleation with patient factors that may be associated with maturation failure. American Journal of Kidney Disease 59:541-549, 2012.
Faculty members: Update your contact information and create a profile.